SIRT1 regulates hepatic vldlr levels

dc.contributor.authorPeyman, Mona
dc.contributor.authorBabin-Ebell, Anna
dc.contributor.authorRodríguez-Rodríguez, Rosalía
dc.contributor.authorRigon, Matilde
dc.contributor.authorAguilar-Recarte, David
dc.contributor.authorVillarroya i Terrade, Joan
dc.contributor.authorPlanavila Porta, Ana
dc.contributor.authorVillarroya i Gombau, Francesc
dc.contributor.authorPalomer Tarridas, Francesc Xavier
dc.contributor.authorBarroso Fernández, Emma
dc.contributor.authorVázquez Carrera, Manuel
dc.date.accessioned2025-06-30T08:31:21Z
dc.date.available2025-06-30T08:31:21Z
dc.date.issued2024-12-01
dc.date.updated2025-06-30T08:31:21Z
dc.description.abstractBackground Endoplasmic reticulum (ER) stress-mediated increases in the hepatic levels of the very low-density lipoprotein (VLDL) receptor (VLDLR) promote hepatic steatosis by increasing the delivery of triglyceride-rich lipoproteins to the liver. Here, we examined whether the NAD(+)-dependent deacetylase sirtuin 1 (SIRT1) regulates hepatic lipid accumulation by modulating VLDLR levels and the subsequent uptake of triglyceride-rich lipoproteins. Methods Rats fed with fructose in drinking water, Sirt1−/− mice, mice treated with the ER stressor tunicamycin with or without a SIRT1 activator, and human Huh-7 hepatoma cells transfected with siRNA or exposed to tunicamycin or different inhibitors were used. Results Hepatic SIRT1 protein levels were reduced, while those of VLDLR were upregulated in the rat model of metabolic dysfunction-associated steatotic liver disease (MASLD) induced by fructose-drinking water. Moreover, Sirt1−/− mice displayed increased hepatic VLDLR levels that were not associated with ER stress, but were accompanied by an increased expression of hypoxia-inducible factor 1α (HIF-1α)-target genes. The pharmacological inhibition or gene knockdown of SIRT1 upregulated VLDLR protein levels in the human Huh-7 hepatoma cell line, with this increase abolished by the pharmacological inhibition of HIF-1α. Finally, SIRT1 activation prevented the increase in hepatic VLDLR protein levels in mice treated with the ER stressor tunicamycin. Conclusions Overall, these findings suggest that SIRT1 attenuates fatty liver development by modulating hepatic VLDLR levels.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec749161
dc.identifier.issn1478-811X
dc.identifier.urihttps://hdl.handle.net/2445/221900
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s12964-024-01666-y
dc.relation.ispartofCell Communication and Signaling, 2024, vol. 22, p. 297
dc.relation.urihttps://doi.org/10.1186/s12964-024-01666-y
dc.rightscc-by (c) Peyman, M. et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationMalalties del fetge
dc.subject.classificationTrastorns del metabolisme dels lípids
dc.subject.otherLiver diseases
dc.subject.otherLipid metabolism disorders
dc.titleSIRT1 regulates hepatic vldlr levels
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
862369.pdf
Mida:
1.88 MB
Format:
Adobe Portable Document Format